In addition, our analysis revealed that a higher CRBN serum ratio between LD initiation and BR (≥1.37) was significantly associated with anemia and earlier relapse to LD, suggesting that an increase in circulating CRBN may reflect disease progression or tumor stress. Here, CRBN is linked to neoplasm.